Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Causal ncRNAs</td><td class="align_center">Interconnected disease with MAFLD</td><td class="align_center">Strong evidence</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">H19</td><td class="align_center">Hepatocellular carcinoma</td><td class="align_center">Northern blot/qPCR/RIP/western blot</td></tr><tr><td class="align_left" rowspan="2">MALAT1</td><td class="align_center">Hepatocellular carcinoma</td><td class="align_center">Apoptosis assay/Luciferase reporter gene assay/metastasis assay/qPCR/qRT-PCR/transwell assay/western blot/wound healing assay</td></tr><tr><td class="align_center">Fatty liver disease</td><td class="align_center">qPCR/RIP/western blot</td></tr><tr><td class="align_left">CircRNA_0046366</td><td class="align_center">Fatty liver disease</td><td class="align_center">Luciferase reporter gene assay/qPCR/western blot</td></tr><tr><td class="align_left">CircRNA_0046367</td><td class="align_center">Fatty liver disease</td><td class="align_center">Luciferase reporter gene assay/qPCR/western blot</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Causal lncRNAs and circRNAs associated with fatty liver disease and PPARs.</div>

PPAR Research

tab3

Table 3

Table 3: Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets 